Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Staurenghi, Giovanni
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD	Completed	3	410	Europe, US, RoW	HLX04-O, ranibizumab	Shanghai Henlius Biotech	Age Related Macular Degeneration	12/24	12/24
RPE65-NHS, NCT04525261: Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene	Completed	N/A	60	Europe		University of Campania "Luigi Vanvitelli", Retina Italia Onlus	Leber Congenital Amaurosis 2, Retinitis Pigmentosa 20	07/20	07/20
Salvetti, Anna Paola
RPE65-NHS, NCT04525261: Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene	Completed	N/A	60	Europe		University of Campania "Luigi Vanvitelli", Retina Italia Onlus	Leber Congenital Amaurosis 2, Retinitis Pigmentosa 20	07/20	07/20

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Staurenghi, Giovanni
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD	Completed	3	410	Europe, US, RoW	HLX04-O, ranibizumab	Shanghai Henlius Biotech	Age Related Macular Degeneration	12/24	12/24
RPE65-NHS, NCT04525261: Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene	Completed	N/A	60	Europe		University of Campania "Luigi Vanvitelli", Retina Italia Onlus	Leber Congenital Amaurosis 2, Retinitis Pigmentosa 20	07/20	07/20
Salvetti, Anna Paola
RPE65-NHS, NCT04525261: Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene	Completed	N/A	60	Europe		University of Campania "Luigi Vanvitelli", Retina Italia Onlus	Leber Congenital Amaurosis 2, Retinitis Pigmentosa 20	07/20	07/20